Peter S. Ludwig

Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis

Kah Teong Soh, Neil Came, Gregory E. Otteson et al. · Cytometry Part B Clinical Cytometry · 2022 · 24 citations · Full text

Medicine, Hematology, Oncology +11

Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N 4 -alkyl-1-β- D -arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5′ → 5′)- N 4 -octadecyl-1-β- d -arabinofuranosylcytosine

Daniel Horber, Rosanna M. C. Cattaneo-Pangrazzi, Prisca von Ballmoos et al. · Journal of Cancer Research and Clinical Oncology · 2000 · 20 citations · Full text

Life Sciences, Biochemistry, Oncology +13

Synthesis and anticancer activities of amphiphilic 5-fluoro-2′-deoxyuridylic acid prodrugs

Peter S. Ludwig, Reto A. Schwendener, Herbert Schott · European Journal of Medicinal Chemistry · 2005 · 17 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Synthesis and in vitro anti-HIV activities of amphiphilic heterodinucleoside phosphate derivatives containing the 2',3'-dideoxynucleosides ddC, AZT and ddI

Herbert Schott, Peter S. Ludwig, Andreas Immelmann et al. · European Journal of Medicinal Chemistry · 1999 · 15 citations

Pharmacy, Chemical Biology, Medicinal Chemistry +14

A New Laboratory Scale Synthesis for the Anticancer Drug 3′<i>-C-</i>Ethynylcytidine

Peter S. Ludwig, Reto A. Schwendener, Herbert Schott · Synthesis · 2002 · 13 citations

Pharmacy, Chemistry, Medicinal Chemistry +11